62 related articles for article (PubMed ID: 15547692)
21. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
22. NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells.
Mima S; Takehara M; Takada H; Nishimura T; Hoshino T; Mizushima T
Carcinogenesis; 2008 Oct; 29(10):1994-2000. PubMed ID: 18586689
[TBL] [Abstract][Full Text] [Related]
23. Oncostatin M induces upregulation of claudin-2 in rodent hepatocytes coinciding with changes in morphology and function of tight junctions.
Imamura M; Kojima T; Lan M; Son S; Murata M; Osanai M; Chiba H; Hirata K; Sawada N
Exp Cell Res; 2007 May; 313(9):1951-62. PubMed ID: 17434483
[TBL] [Abstract][Full Text] [Related]
24. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
Martin TA; Harrison GM; Watkins G; Jiang WG
J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
[TBL] [Abstract][Full Text] [Related]
25. Changes in the expression of claudins in active ulcerative colitis.
Oshima T; Miwa H; Joh T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S146-50. PubMed ID: 19120888
[TBL] [Abstract][Full Text] [Related]
26. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
[TBL] [Abstract][Full Text] [Related]
27. Tight junction proteins and perineurial cells in neurofibromas.
Pummi KP; Aho HJ; Laato MK; Peltonen JT; Peltonen SA
J Histochem Cytochem; 2006 Jan; 54(1):53-61. PubMed ID: 16087703
[TBL] [Abstract][Full Text] [Related]
28. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
Deissler H; Deissler H; Lang S; Lang GE
Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543
[TBL] [Abstract][Full Text] [Related]
29. Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via Claudin-5 modulation.
Martin TA; Das T; Mansel RE; Jiang WG
J Cell Biochem; 2006 Aug; 98(5):1308-19. PubMed ID: 16514648
[TBL] [Abstract][Full Text] [Related]
30. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
[TBL] [Abstract][Full Text] [Related]
31. Claudin-16/paracellin-1, cloning, expression, and its role in tight junction functions in cancer and endothelial cells.
Martin TA; Jiang WG
Methods Mol Biol; 2011; 762():383-407. PubMed ID: 21717372
[TBL] [Abstract][Full Text] [Related]
32. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers.
Suzuki M; Kato-Nakano M; Kawamoto S; Furuya A; Abe Y; Misaka H; Kimoto N; Nakamura K; Ohta S; Ando H
Cancer Sci; 2009 Sep; 100(9):1623-30. PubMed ID: 19555390
[TBL] [Abstract][Full Text] [Related]
34. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
35. Effect of chymotrypsin C and related proteins on pancreatic cancer cell migration.
Wang H; Sha W; Liu Z; Chi CW
Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):362-71. PubMed ID: 21460362
[TBL] [Abstract][Full Text] [Related]
36. Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway.
Meng X; Liu P; Wu Y; Liu X; Huang Y; Yu B; Han J; Jin H; Tan X
Bosn J Basic Med Sci; 2020 Feb; 20(1):106-116. PubMed ID: 31242404
[TBL] [Abstract][Full Text] [Related]
37. Interaction of tRNA with MEK2 in pancreatic cancer cells.
Wang X; Chow CR; Ebine K; Lee J; Rosner MR; Pan T; Munshi HG
Sci Rep; 2016 Jun; 6():28260. PubMed ID: 27301426
[TBL] [Abstract][Full Text] [Related]
38. Characterization of cancer cell dissociation factor in a highly invasive pancreatic cancer cell line.
Kurizaki T; Egami H; Hirota M; Akagi J; Ohmachi H; Yamamoto S; Ogawa M
Cancer; 1995 Mar; 75(6 Suppl):1554-61. PubMed ID: 7889490
[TBL] [Abstract][Full Text] [Related]
39. The role of tight junctions in cancer metastasis.
Martin TA
Semin Cell Dev Biol; 2014 Dec; 36():224-31. PubMed ID: 25239399
[TBL] [Abstract][Full Text] [Related]
40. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics.
Wang J; Seo JW; Kare AJ; Schneider M; Tumbale SK; Wu B; Raie MN; Pandrala M; Iagaru A; Brunsing RL; Charville GW; Park WG; Ferrara KW
bioRxiv; 2024 Jan; ():. PubMed ID: 38249519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
